Cite
HARVARD Citation
Fukuokaya, W. et al. (2021). Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab. BJU international. pp. 90-95. [Online].